Daniel J. Kruger, PhD
Research Associate Professor
Research Scientist
Psychology
Public Health
Jacobs School of Medicine and Biomedical Sciences
ÃÛÌÒ´«Ã½, State ÃÛÌÒ´«Ã½ of New York
Contact Information
UB Downtown Gateway
77 Goodell St.
Suite 420
Buffalo, NY 14203
Email: djkruger@buffalo.edu
Primary Research Areas
Medical Cannabis; novel and emerging cannabinoids; therapeutic use of psychedelics; integration of Cannabis and psychedelics with healthcare and health professions education
Selected Publications
Kruger, D.J., Barron, J., Herberholz, M., & Boehnke, K.F. (2023). Preferences and support for psychedelic policies and practices among those using psychedelics. Journal of Psychoactive Drugs.
Kruger, D.J., Bone, C.B., Meacham, M.C., Klein, C., & Kruger, J. S. (2023). THC-O-acetate: Scarce evidence for a psychedelic cannabinoid. Journal of Psychoactive Drugs.
Bone, C.B., Klein, C., Munger, K., Strongin, R.M., Kruger, D.J., Meacham, M.C., & Kruger, J. S. (2023). Reviewing the risk of ketene formation in dabbing and vaping THC-O-acetate. Cannabis and Cannabinoid Research.
Kruger, D.J., Gerlach, J., Kruger, J.S., Mokbel, M.M., Clauw, D.J., & Boehnke, K.F. (2023). Physicians’ attitudes and practices regarding Cannabis and recommending medical Cannabis use. Cannabis and Cannabinoid Research.
Kruger, D.J., Enghoff, O., Herberholz, M., Barron, J., & Boehnke, K.F. (2023). “How do I learn more about this?”: Utilization and trust of psychedelic information sources among people naturalistically using psychedelics. Journal of Psychoactive Drugs.
Kruger, D.J. & Kruger, J.S. (2023). Consumer experiences with delta-8-THC: Medical use, pharmaceutical substitution, and comparisons with delta-9-THC. Cannabis and Cannabinoid Research, 8, 166-173.
Kruger, D.J., Karahmet, A., Kaplan, S.M., Redfield, J., Stacy, T., Agarwal, V., Faqqouseh, M., & Bone, C.B. (2023). Social media discussions on THC-O-acetate: A content analysis. Cannabis, 6 (2).
Kruger, D.J., Glynos, N.G., Fields, C.W., Herberholz, M., & Boehnke, K.F. (2023). An assessment of psychedelic knowledge among people using psychedelics naturalistically. Journal of Psychoactive Drugs, 55, 420-424.
Allard, N.C., Kruger, J.S., & Kruger, D.J. (2023). Cannabis advertising policies in the United States: State-level variation and comparison with Canada. Cannabis and Cannabinoid Research, 8, 505-509.
Holman, A., Kruger, D.J., Lucas, P., Ong, K., Bergmans, R.S., Boehnke, K.F. (2023). Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: The Canadian context. Journal of Cannabis Research, 4, 32.
Kruger, J.S., & Kruger, D.J. (2022). Delta-8-THC: Delta-9-THC’s nicer younger sibling? Journal of Cannabis Research, 4, 4.
Kruger, D.J., Mokbel, M.M., Clauw, D.J., & Boehnke, K.F. (2022). Assessing healthcare providers’ knowledge of medical Cannabis. Cannabis and Cannabinoid Research, 7, 501-507.